Company news
Xlife Sciences Ltd. (SIX:XLS) news
Xlife Sciences Ltd. news releases on 6ix. Latest, Apr 28, 2026: Xlife Sciences AG publishes 2025 Annual Report: Strategic positioning and preparation of key…
Press releases & updates
Xlife Sciences AG publishes 2025 Annual Report: Strategic positioning and preparation of key capital market transactions
April 28, 2026
Xlife Sciences AG Announces Transition to the Main Segment of SIX Swiss Exchange to Strengthen Market Presence
December 23, 2025
Xlife Sciences AG Announces Exit of 12 Project Companies to Grupo Landsteiner and the Creation of a Scalable Transcontinental Life Sciences Platform
December 8, 2025
Xlife Sciences AG Delivers Breakthrough in Early Alzheimer’s Detection, Unlocking Major Market Opportunity
December 1, 2025
Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process Following U.S. Government Shutdown
November 28, 2025
Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a Strategic Core
October 16, 2025
Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AG’s NASDAQ Listing and Internationalization
September 23, 2025
Xlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4
July 17, 2025
Xlife Sciences AG: Successful General Meeting and Growth Prospects for 2025
June 24, 2025
Strategic Collaboration Between Xlife Sciences AG, Huraypositive Corp., and OncoMASTER Inc. to Boost Digital Health and Precision Oncology in Asia
June 16, 2025
Strategic Alliance Between Xlife Sciences AG, JIPYONG LLC and JIPYONG IP to Accelerate Korean Life Sciences Ventures’ Access to Global Capital Markets
June 13, 2025
Xlife Sciences AG Announces Strategic Collaboration between Portfolio Company Firstgene Life Sciences and Hovione in the Field of Gene Therapy
May 6, 2025